ES2037742T3 - Procedimiento de obtencion de una composicion para administracion intravenosa. - Google Patents

Procedimiento de obtencion de una composicion para administracion intravenosa.

Info

Publication number
ES2037742T3
ES2037742T3 ES198787850029T ES87850029T ES2037742T3 ES 2037742 T3 ES2037742 T3 ES 2037742T3 ES 198787850029 T ES198787850029 T ES 198787850029T ES 87850029 T ES87850029 T ES 87850029T ES 2037742 T3 ES2037742 T3 ES 2037742T3
Authority
ES
Spain
Prior art keywords
composition
intravenous administration
procedure
obtaining
pregnanolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787850029T
Other languages
English (en)
Spanish (es)
Inventor
Roland Ingolf Jeppsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Application granted granted Critical
Publication of ES2037742T3 publication Critical patent/ES2037742T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
ES198787850029T 1986-02-13 1987-01-29 Procedimiento de obtencion de una composicion para administracion intravenosa. Expired - Lifetime ES2037742T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8600632A SE8600632D0 (sv) 1986-02-13 1986-02-13 Novel pharmaceutical composition

Publications (1)

Publication Number Publication Date
ES2037742T3 true ES2037742T3 (es) 1993-07-01

Family

ID=20363448

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787850029T Expired - Lifetime ES2037742T3 (es) 1986-02-13 1987-01-29 Procedimiento de obtencion de una composicion para administracion intravenosa.

Country Status (14)

Country Link
US (1) US5028600A (OSRAM)
EP (1) EP0233849B1 (OSRAM)
JP (1) JPH0788305B2 (OSRAM)
AT (1) ATE64526T1 (OSRAM)
CA (1) CA1301651C (OSRAM)
DE (1) DE3770830D1 (OSRAM)
DK (1) DK175504B1 (OSRAM)
ES (1) ES2037742T3 (OSRAM)
FI (1) FI88676C (OSRAM)
GR (1) GR3002299T3 (OSRAM)
HK (1) HK83293A (OSRAM)
NO (1) NO175040B (OSRAM)
SE (1) SE8600632D0 (OSRAM)
SG (1) SG102892G (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302295D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab New pharmaceutical composition
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
AU8779898A (en) * 1997-08-11 1999-03-01 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
ES2211151T3 (es) 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
AU2002241738A1 (en) * 2000-12-29 2002-07-16 The Trustees Of Columbia University In The City Of New York Use of iv emulsions with different triglyceride composition, particle size and apolipoprotein e for targeted tissue delivery of hydrophobic compounds
US8182824B2 (en) * 2002-07-02 2012-05-22 Nycomed Gmbh Ciclesonide-containing sterile aqueous suspension
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
KR20070058608A (ko) * 2004-09-13 2007-06-08 바라트 쎄럼스 앤드 백신스 리미티드 항미생물 방부 효능을 갖는 정맥 내 투여를 위한 안정한에멀젼 조성물
EP2663326B2 (en) * 2011-01-14 2021-09-29 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
WO2013043985A1 (en) * 2011-09-23 2013-03-28 The Regents Of The University Of California Edible oils to enhance delivery of orally administered steroids
EP4295908A3 (en) 2012-01-23 2024-03-20 Sage Therapeutics, Inc. Neuroactive steroid formulations comprising a complex of allopregnanolone and sulfobutyl ether beta-cyclodextrin
US20140050789A1 (en) 2012-08-13 2014-02-20 The Regents Of The University Of California Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
NZ705410A (en) 2012-08-21 2018-03-23 Sage Therapeutics Inc Methods of treating epilepsy or status epilepticus
JP2016501876A (ja) 2012-11-30 2016-01-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ステロイドの抗痙攣活性
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
CA3158448A1 (en) 2016-03-08 2017-09-14 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CA3123002A1 (en) * 2018-12-10 2020-06-18 Halo Science LLC Stable formulations of anesthetics and associated dosage forms
CA3151334C (en) * 2019-08-19 2024-04-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Topical neurosteroid formulations
US11969434B1 (en) 2022-08-29 2024-04-30 Lipocine Inc. Oral allopregnanolone compositions and methods of use
CN114344309B (zh) * 2021-12-30 2024-02-06 南京迈诺威医药科技有限公司 一种别孕烷醇酮衍生物自乳化制剂及其制备方法
US12186327B2 (en) 2022-08-29 2025-01-07 Lipocine Inc. Oral allopregnanolone compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1215702B (de) * 1962-07-03 1966-05-05 Merck Ag E Verfahren zur Herstellung von 1alpha-Alkylthio-3-keto-androstanen
CA895860A (en) * 1969-11-05 1972-03-21 Kruger Gunther PROCESS FOR THE PREPARATION OF 3.alpha.-HYDROXY-5.beta.-PREGNAN-20-ONE
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS5716818A (en) * 1981-04-25 1982-01-28 Green Cross Corp:The Steroid fatty emulsion
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液

Also Published As

Publication number Publication date
SG102892G (en) 1992-12-04
DK62187D0 (da) 1987-02-06
GR3002299T3 (en) 1992-12-30
JPH0788305B2 (ja) 1995-09-27
DE3770830D1 (de) 1991-07-25
DK175504B1 (da) 2004-11-15
NO870560L (no) 1987-08-14
US5028600A (en) 1991-07-02
JPS62192322A (ja) 1987-08-22
HK83293A (en) 1993-08-20
FI870589L (fi) 1987-08-14
NO175040B (no) 1994-05-16
FI88676B (fi) 1993-03-15
SE8600632D0 (sv) 1986-02-13
FI870589A0 (fi) 1987-02-12
NO870560D0 (no) 1987-02-12
EP0233849B1 (en) 1991-06-19
EP0233849A1 (en) 1987-08-26
CA1301651C (en) 1992-05-26
DK62187A (da) 1987-08-14
FI88676C (fi) 1993-06-28
ATE64526T1 (de) 1991-07-15
NO175040C (OSRAM) 1994-08-24

Similar Documents

Publication Publication Date Title
ES2037742T3 (es) Procedimiento de obtencion de una composicion para administracion intravenosa.
KR890004709A (ko) 항원충제로서의 아지트로마이신 및 이의 유도체
SE8504580D0 (sv) Platt-liknande preparat
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
ES2034365T3 (es) Una goma de mascar con blandura duradera.
SE8405464L (sv) Komposition for oftalmologiska applikationer
SE8702563D0 (sv) Pharmaceutical compositions
ATE30583T1 (de) Vitamin-d3-derivate.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2052533T3 (es) Composicion farmaceutica que comprende 2',3'-didesoxicitidin-2'-eno (2',3'-dideshidrocitidina) para tratar pacientes infectados con retrovirus.
ES2045768T3 (es) Composiciones topicas que contienen defibrotida.
SE8303401D0 (sv) Beredning och dess anvendning
ES2061997T3 (es) Agentes antiparasitos.
DE3870154D1 (de) Phenol enthaltende, fluessige antitussiv-zusammensetzungen.
DK0509009T3 (da) Anvendelse af et middel, hvis hovedbestanddel er et triglycerid, til fremstilling af et lægemiddel
AR240858A2 (es) Una composicion fungicida
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
PT90127A (pt) Processo para a preparacao de composicoes farmaceuticas com accao analgesica que contem 4-aril-4-piperidino (ou pirrolidino ou hexa-hidroazepino)-carbinois ou os seus analogos heterociclicos
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
DK344489D0 (da) Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
GR3008746T3 (OSRAM)
ES2039211T3 (es) Nuevos n-glicosilamidoderivados, procedimientos para su obtencion y su empleo como medicamentos.
ES2069539T3 (es) Emulsiones estables en agua de fluidos de hidruro de silicona.
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
ATE73136T1 (de) Verfahren zur herstellung von 6alpha, 9alphadifluor-11beta, 17alpha-dihydroxy-16alpha-methyl4-pregnen-3,20-dion und dessen derivate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 233849

Country of ref document: ES